Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지

Suppression of DMBA/Croton Oil-induced Mouse Skin Tumor Promotion by Ardisia Crispa Root Hexane Extract

Roslida, AH;Fezah, O;Yeong, LT

  • Published : 20110300
⟨ Previous Next ⟩

Abstract

Ardisia crispa (Family: Myrsinaceae) has been used as a traditional medicine for various ailments. Previous studies showed that Ardisia crispa possesses antimetastatic and anti-inflammatory properties. Nevertheless, research done on the plant is still limited. Therefore, the present study was designed to evaluate the suppression effect of Ardisia crispa root hexane (ACRH) extract on 7, 12-dimethylbenz (${\alpha}$) anthracene (DMBA)-induced mice skin tumor promotion in ICR mice with topical application twice weekly for 10 weeks. Results showed significant difference between treatment groups (mice treated with 30 mg/kg, 100 mg/kg and 300 mg/kg of ACRH extract; denoted as group I, II and III respectively) for tumor incidence and tumor burden (P<0.05). Significant reduction in tumor incidence (20%), tumor burden ($1.5{\pm}0.50$), tumor volume ($2.49{\pm}1.70$) and delayed latency period of tumor formation was observed in group I (30 mg/kg) in comparison to carcinogen control. This study indicates that ACRH extract could be a promising skin tumor promotion suppressing agent at a lower dosage (30 mg/kg). Further studies are required to elucidate the underlying mechanism(s) leading to this effect.

Keywords

References

  1. Agarwal R and Mukhtar H (1991). Cutaneous chemical carcinogenesis. In Mukhtar H (ed) Pharmacology of the Skin, CRC Press, Boca Raton, FL. 371-87.
  2. Aggarwal BB (2004). Nuclear factor-$kappa\beta$: the enemy within. Cancer Cell, 6, 203-8. https://doi.org/10.1016/j.ccr.2004.09.003
  3. Ara G and Teicher BA (1996). Cyclooxygenase and lipoxygenase inhibitors in cancer therapy. PLEFA, 54, 3-16.
  4. Bariwal JB, Upadhyay KD, Manvar AT, et al (2008). 1,5-Benzothiazepine, a versatile pharmacophore: a review. Eur J Med Chem, 43, 2279-90. https://doi.org/10.1016/j.ejmech.2008.05.035
  5. Berenblum I (1941). The mechanism of cocarcinogenesis: a study of the significance of cocarcinogenic action and related phenomena. Cancer Res, 1, 807-14.
  6. Boutwell RK (1974). The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol, 2, 419-43.
  7. Boutwell RK (1964). Some biological aspects of skin carcinogenesis. Prog Exp Tumor Res, 4, 207-50.
  8. Burkill IH (1966). A Dictionary of the Economic Plants of the Malay Peninsula. Vol 1 (A-H), ministry of agriculture and cooperative, Kuala Lumpur. 218-23.
  9. Butler MS (2005). Natural products to drugs: natural product compounds in clinical trials. Natural Product Rep, 22, 162-95. https://doi.org/10.1039/b402985m
  10. Cancer Research UK (2008). Skin Cancer Overview. http://info.cancerresearchuk.org/healthyliving/sunsmart/skincancer/
  11. Chen J, Pipoly JJ (1996). Myrsinaceae. In 'Flora of China 15'. Science press and missouri botanical garden press, St Louis. 1-38.
  12. Chung J, Han J, Hwang E, et al (2003). Dual mechanism of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes. FASEB, 17, 1913-5. https://doi.org/10.1096/fj.02-0914fje
  13. Craig WJ (1997). Phytochemicals: guardians of our health. J Am Diet Assoc, 97, S199-204. https://doi.org/10.1016/S0002-8223(97)00765-7
  14. de Mejia EG, Ramirez-Mares MV, Arce-Popoca E, et al (2004). Inhibition of liver carcinogenesis in Wistar rats by consumption of an aqueous extract from leaves of Ardisia compressa. Food Chem Toxicol, 42, 509-16. https://doi.org/10.1016/j.fct.2003.10.016
  15. Deelman HT (1927). The part played by injury and repair in the development of cancer. Br Med J, 1, 872.
  16. DiGiovanni J (1992). Multistage carcinogenesis in mouse skin. Pharmac Ther, 54, 63-128. https://doi.org/10.1016/0163-7258(92)90051-Z
  17. Duke JA and Ayensu ES (1985). Medicinal plants of China. Reference publications, Inc.
  18. Flavin DF (1984). Toxicity, tumor promotion, and carcinogenesis in relation to excessive dosage. Regul Toxicol Pharm, 4, 372-9. https://doi.org/10.1016/0273-2300(84)90048-5
  19. Girit IC, Jure-Kunkel M, McIntyre KW (2008). A structured light-based system for scanning subcutaneous tumors in laboratory animals. Comp Med, 58, 264-70.
  20. Hong WK and Sporn MB (1997). Recent advances in chemoprevention of cancer. Science, 278, 1073-7. https://doi.org/10.1126/science.278.5340.1073
  21. Huang MT, Lysz T, Ferraro T, et al (1991). Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res, 51, 813-9.
  22. Ito H, Miyake M, Nishitani E, et al (1999). Anti-tumor promoting activity of polyphenols from Cowania Mexicana and Colegyne ramosissima. Cancer Lett, 143, 5-13. https://doi.org/10.1016/S0304-3835(99)00160-3
  23. Jansakul C, Baumann H, Kenne L, Samuelsson G (1987). Ardisiacrispin A and B, two utero-contracting saponins from Ardisia crispa. Planta Medica, 53, 405-9. https://doi.org/10.1055/s-2006-962758
  24. Jansakul C (1995). Some pharmacological studies of ardisiacrispin B, an utero-contracting saponin, isolated from Ardisia crispa. J Sci Soc Thailand, 21, 11-26. https://doi.org/10.2306/scienceasia1513-1874.1995.21.011
  25. Kang YH, Kim WH, Park MK, et al (2001). Antimetastatic and antitumor effects of benzoquinonoid AC7-1 from Ardisia crispa. Int J Cancer, 93, 736-40. https://doi.org/10.1002/ijc.1384
  26. Kellen JA (1999). Chemoprevention of cancer: an ongoing saga. In Vivo, 13, 423-6.
  27. Kelloff GJ (2000). Perspectives on cancer chemoprevention research and drug development. Adv Cancer Res, 78, 199-334.
  28. Lau MF, Roslida AH, Sabrina S, et al (2009). Anti-inflammatory and anti-pyretic effects of hexane fraction of Ardisia crispa Thunb, D.C. Pharmacologyonline, 3, 29-39.
  29. Lee SJ, Sung JH, Lee SJ, et al (1999). Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer Lett, 144, 39-43. https://doi.org/10.1016/S0304-3835(99)00188-3
  30. Mann J (2002). Natural products in cancer chemotherapy: past, present and future. Nat Rev Cancer, 2, 143. https://doi.org/10.1038/nrc723
  31. Marks R (1976). Epidermal growth control mechanism, hyperplasia, and tumor promotion in the skin. Cancer Res, 36, 1379-2643.
  32. Muhammad Z and Mustafa AM (1994). Traditional Malay medicinal plants. Fajar Bakti, Kuala Lumpur, 39-41.
  33. Newman DJ and Cragg GM (2005). The discovery of anticancer drugs from natural sources. In 'Natural Products: Drug Discovery and Therapeutic Medicine', Eds Zhang L and Demain AL. Humana Press, New Jersey pp129.
  34. Newman DJ, Cragg GM, Snader KM (2003). Natural products as sources of new drugs over the period 1981-2002. J Nat Prod, 66, 1022-37. https://doi.org/10.1021/np030096l
  35. Nishino H, Yoshioka K, Iwashima A, et al (1986). Glycyrrhetic acid inhibits tumor-promoting activity of teleocidin and 12-O-tetradecanoylphorbol-13-acetate in two-stage mouse skin carcinogenesis. Jpn J Cancer Res, 77, 33-8.
  36. Nishino H, Murakoshi M, Mou XY, et al (2005). Cancer prevention by phytochemicals. Oncology, 69, 38-40. https://doi.org/10.1159/000086631
  37. Noor Rain A, Khozirah S, Mohd Ridzuan MAR, et al (2007). Antiplasmodial properties of some Malaysian medicinal plants. Tropical Biomedicine, 24, 29-35.
  38. Ramawat KG (2007). Production of alkaloids. In 'Biotechnology: Secondary Metabolites, Plants and Microbes', Eds Ramawat KG and Merillon JM. Science Publishers, New Hampshire pp179.
  39. Rao AV and Shen H (2002). Effect of low dose lycopene intake on lycopene bioavailability and oxidative stress. Nutr Res, 22, 1125-31. https://doi.org/10.1016/S0271-5317(02)00430-X
  40. Roslida AH and Kim KH (2008). Anti-inflammatory and anti-hyperalgesic effects of Ardisia crispa Thunb. D.C. Pharmacognosy Magazine, 4, 262-8.
  41. Russo GL (2007). Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol, 74, 533-44. https://doi.org/10.1016/j.bcp.2007.02.014
  42. Schulte-Herman R, Timmermann-Trosiener I, Schupper J (1983). Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Cancer Res, 43, 839-44.
  43. Sengupta A, Ghosh S, Bhattacharjee S, et al (2004). Indian food ingredients and cancer prevention- an experimental evaluation of anticarcinogenic effects of garlic in rat colon. Asian Pac J Cancer Prev, 5, 126-32.
  44. Shankar R, Chakravarti B, Singh US, et al (2009). Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as apotential new class of anti-breast cancer agents. Bioorgan Med Chem, 17, 3847-56. https://doi.org/10.1016/j.bmc.2009.04.032
  45. Soltis PS and Soltis DE (2001). Molecular systematics: assembling and using the tree of life. Taxon, 49, 451-7.
  46. Sporn MB, Dunlop NM, Newton DL, et al (1976). Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc, 35, 1332-8.
  47. Stewart BW, Kleihues P (2003). Cancer facts and figures 2004. IARC press, world cancer report, American cancer society.
  48. World Health Organization. Ultraviolet radiation and the INTERSUN Programme. http://www.who.int/uv/faq/skincancer/en/index1.html
  49. World Health Organization. Cancer. http://www.who.int/topics/cancer/en/